Daiwa Securities Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2K | Sell |
1,006
-7,555
| -88% | -$15K | ﹤0.01% | 1214 |
|
2025
Q1 | $29K | Sell |
8,561
-276
| -3% | -$935 | ﹤0.01% | 1057 |
|
2024
Q4 | $65K | Buy |
8,837
+181
| +2% | +$1.33K | ﹤0.01% | 1036 |
|
2024
Q3 | $81K | Sell |
8,656
-157
| -2% | -$1.47K | ﹤0.01% | 1025 |
|
2024
Q2 | $71K | Buy |
8,813
+7,781
| +754% | +$62.7K | ﹤0.01% | 1051 |
|
2024
Q1 | $15K | Buy |
1,032
+155
| +18% | +$2.25K | ﹤0.01% | 1141 |
|
2023
Q4 | $7K | Hold |
877
| – | – | ﹤0.01% | 1177 |
|
2023
Q3 | $4K | Hold |
877
| – | – | ﹤0.01% | 1168 |
|
2023
Q2 | $6K | Hold |
877
| – | – | ﹤0.01% | 1159 |
|
2023
Q1 | $5K | Buy |
877
+291
| +50% | +$1.66K | ﹤0.01% | 1143 |
|
2022
Q4 | $4K | Hold |
586
| – | – | ﹤0.01% | 1161 |
|
2022
Q3 | $6K | Hold |
586
| – | – | ﹤0.01% | 1147 |
|
2022
Q2 | $6K | Buy |
586
+128
| +28% | +$1.31K | ﹤0.01% | 1149 |
|
2022
Q1 | $8K | Hold |
458
| – | – | ﹤0.01% | 1144 |
|
2021
Q4 | $9K | Sell |
458
-73
| -14% | -$1.43K | ﹤0.01% | 1150 |
|
2021
Q3 | $13K | Buy |
531
+240
| +82% | +$5.88K | ﹤0.01% | 1119 |
|
2021
Q2 | $8K | Hold |
291
| – | – | ﹤0.01% | 1048 |
|
2021
Q1 | $9K | Buy |
291
+15
| +5% | +$464 | ﹤0.01% | 1046 |
|
2020
Q4 | $13K | Sell |
276
-543
| -66% | -$25.6K | ﹤0.01% | 999 |
|
2020
Q3 | $27K | Buy |
819
+107
| +15% | +$3.53K | ﹤0.01% | 963 |
|
2020
Q2 | $21K | Hold |
712
| – | – | ﹤0.01% | 1009 |
|
2020
Q1 | $21K | Hold |
712
| – | – | ﹤0.01% | 996 |
|
2019
Q4 | $20K | Sell |
712
-73
| -9% | -$2.05K | ﹤0.01% | 1006 |
|
2019
Q3 | $14K | Hold |
785
| – | – | ﹤0.01% | 1003 |
|
2019
Q2 | $19K | Hold |
785
| – | – | ﹤0.01% | 1001 |
|
2019
Q1 | $7K | Buy |
785
+384
| +96% | +$3.42K | ﹤0.01% | 1045 |
|
2018
Q4 | $4K | Hold |
401
| – | – | ﹤0.01% | 1059 |
|
2018
Q3 | $5K | Hold |
401
| – | – | ﹤0.01% | 1067 |
|
2018
Q2 | $5K | Hold |
401
| – | – | ﹤0.01% | 1083 |
|
2018
Q1 | $7K | Buy |
+401
| New | +$7K | ﹤0.01% | 1045 |
|